Logo image of PSNYW

POLESTAR AUTO CLASS C-1 ADS (PSNYW) Stock Fundamental Analysis

NASDAQ:PSNYW - Nasdaq -

0.2299  +0 (+2.18%)

Premarket: 0.2288 0 (-0.48%)

Fundamental Rating

1

PSNYW gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 42 industry peers in the Automobiles industry. PSNYW has a bad profitability rating. Also its financial health evaluation is rather negative. PSNYW is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year PSNYW has reported negative net income.
In the past 5 years PSNYW always reported negative net income.
PSNYW had a negative operating cash flow in each of the past 5 years.
PSNYW Yearly Net Income VS EBIT VS OCF VS FCFPSNYW Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -500M -1B -1.5B -2B

1.2 Ratios

PSNYW has a Return On Assets of -37.14%. This is in the lower half of the industry: PSNYW underperforms 70.00% of its industry peers.
Industry RankSector Rank
ROA -37.14%
ROE N/A
ROIC N/A
ROA(3y)-23.75%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PSNYW Yearly ROA, ROE, ROICPSNYW Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 200 -200 -400 -600 -800

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for PSNYW so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PSNYW Yearly Profit, Operating, Gross MarginsPSNYW Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 50 -50 -100 -150 -200

0

2. Health

2.1 Basic Checks

PSNYW does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PSNYW remains at a similar level compared to 1 year ago.
PSNYW has a worse debt/assets ratio than last year.
PSNYW Yearly Shares OutstandingPSNYW Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 500M 1B 1.5B 2B
PSNYW Yearly Total Debt VS Total AssetsPSNYW Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 1B 2B 3B 4B

2.2 Solvency

Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC8.02%
PSNYW Yearly LT Debt VS Equity VS FCFPSNYW Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 1B -1B -2B

2.3 Liquidity

PSNYW has a Current Ratio of 0.61. This is a bad value and indicates that PSNYW is not financially healthy enough and could expect problems in meeting its short term obligations.
PSNYW's Current ratio of 0.61 is on the low side compared to the rest of the industry. PSNYW is outperformed by 77.50% of its industry peers.
A Quick Ratio of 0.61 indicates that PSNYW may have some problems paying its short term obligations.
The Quick ratio of PSNYW (0.61) is worse than 67.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.61
Quick Ratio 0.61
PSNYW Yearly Current Assets VS Current LiabilitesPSNYW Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 1B 2B 3B

5

3. Growth

3.1 Past

PSNYW shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -347.22%.
The Revenue for PSNYW has decreased by -22.12% in the past year. This is quite bad
Measured over the past years, PSNYW shows a very strong growth in Revenue. The Revenue has been growing by 57.38% on average per year.
EPS 1Y (TTM)-347.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.29%
Revenue 1Y (TTM)-22.12%
Revenue growth 3Y57.38%
Revenue growth 5YN/A
Sales Q2Q%-16.43%

3.2 Future

The Earnings Per Share is expected to grow by 16.85% on average over the next years. This is quite good.
The Revenue is expected to grow by 44.82% on average over the next years. This is a very strong growth
EPS Next Y-31.08%
EPS Next 2Y2.92%
EPS Next 3Y10.88%
EPS Next 5Y16.85%
Revenue Next Year22.01%
Revenue Next 2Y58.27%
Revenue Next 3Y57.29%
Revenue Next 5Y44.82%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PSNYW Yearly Revenue VS EstimatesPSNYW Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B 20B 25B
PSNYW Yearly EPS VS EstimatesPSNYW Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -0.2 -0.4

0

4. Valuation

4.1 Price/Earnings Ratio

PSNYW reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year PSNYW is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PSNYW Price Earnings VS Forward Price EarningsPSNYW Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PSNYW Per share dataPSNYW EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.92%
EPS Next 3Y10.88%

0

5. Dividend

5.1 Amount

PSNYW does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

POLESTAR AUTO CLASS C-1 ADS

NASDAQ:PSNYW (1/17/2025, 8:22:36 PM)

Premarket: 0.2288 0 (-0.48%)

0.2299

+0 (+2.18%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)08-29 2024-08-29/bmo
Earnings (Next)N/A N/A
Inst Owners3.47%
Inst Owner Change-0.04%
Ins Owners62.98%
Ins Owner ChangeN/A
Market Cap485.17M
Analysts50
Price Target0.22 (-4.31%)
Short Float %0%
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.91%
Min EPS beat(2)4.17%
Max EPS beat(2)29.66%
EPS beat(4)3
Avg EPS beat(4)19.61%
Min EPS beat(4)-9.65%
Max EPS beat(4)54.25%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-31.32%
Min Revenue beat(2)-42.82%
Max Revenue beat(2)-19.82%
Revenue beat(4)0
Avg Revenue beat(4)-25.98%
Min Revenue beat(4)-42.82%
Max Revenue beat(4)-14.8%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.44%
PT rev (3m)-24.21%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)5.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)15.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.23
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.5
EYN/A
EPS(NY)-0.37
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.98
BVpS-0.86
TBVpS-0.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -37.14%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-23.75%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.61
Quick Ratio 0.61
Altman-Z N/A
F-ScoreN/A
WACC8.02%
ROIC/WACCN/A
Cap/Depr(3y)341.13%
Cap/Depr(5y)402.63%
Cap/Sales(3y)21.26%
Cap/Sales(5y)82.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-347.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.29%
EPS Next Y-31.08%
EPS Next 2Y2.92%
EPS Next 3Y10.88%
EPS Next 5Y16.85%
Revenue 1Y (TTM)-22.12%
Revenue growth 3Y57.38%
Revenue growth 5YN/A
Sales Q2Q%-16.43%
Revenue Next Year22.01%
Revenue Next 2Y58.27%
Revenue Next 3Y57.29%
Revenue Next 5Y44.82%
EBIT growth 1Y-68.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45.4%
EBIT Next 3Y32.43%
EBIT Next 5Y23.38%
FCF growth 1Y-36.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-71.66%
OCF growth 3YN/A
OCF growth 5YN/A